689-11-2

Usage

Uses

Used in Chemical Production:
N-sec-Butylurea is used as an intermediate in the chemical industry for the synthesis of a range of chemical products. Its role in the production process is crucial, as it serves as a building block for creating more complex molecules and compounds.
Used in Pharmaceutical Industry:
N-sec-Butylurea is used as a precursor in the development of pharmaceutical compounds. Its chemical structure allows for the creation of new drug molecules, contributing to the advancement of medicinal chemistry.
Used in Agricultural Chemicals:
In the agricultural sector, N-sec-Butylurea is employed as a starting material for the production of agrochemicals. Its versatility in chemical reactions enables the creation of products that can be used in crop protection and other agricultural applications.
Safety and Environmental Considerations:
N-sec-Butylurea is used with caution due to its potential hazards, such as skin or eye irritation and harmful effects if inhaled or ingested. It is essential to implement safety measures to prevent exposure and to minimize its release into the environment, as it could be harmful to aquatic life. Proper handling and disposal protocols are necessary to mitigate these risks.

InChI:InChI=1/C5H12N2O/c1-3-4(2)7-5(6)8/h4H,3H2,1-2H3,(H3,6,7,8)/t4-/m1/s1

Upstream product

• 57-13-6 urea 
• 78-93-3 butanone 
• 33966-50-6 SEC-BUTYLAMINE 
• 556-89-8 nitrourea 
• 590-28-3 potassium cyanate 
• 1118-02-1 trimethylsilyl isocyanate 
• 13250-12-9 (R)-sec-butylamine 
• 4461-33-0 benzoyl isocyanate 

Downstream Products

• 92033-17-5 3-o-Toluoyl-1-i-butylharnstoff 

Relevant academic research and scientific papers

Deuterated benzylaminopyrimidine diketone derivative and application thereof

The invention discloses a deuterated benzylaminopyrimidine dione derivative and an application thereof, and a pharmaceutical composition containing the deuterated benzylaminopyrimidine dione derivative, and the deuterated benzylaminopyrimidine dione derivative and the pharmaceutical composition can be used for inhibiting the activity of myosin. The invention also relates to a method for preparingthe compound and the pharmaceutical composition, and an application of the compound and the pharmaceutical composition in treating hypertrophic cardiomyopathy and related heart diseases.

Superparamagnetic Fe3O4 Nanoparticles in a Deep Eutectic Solvent: An Efficient and Recyclable Catalytic System for the Synthesis of Primary Carbamates and Monosubstituted Ureas

Superparamagnetic Fe3O4 nanoparticles were used to synthesize various primary carbamates as well as monosubstituted and N,N-disubstituted ureas. This efficient phosgene-free process used urea as an eco-friendly carbonyl source in the presence of a biocompatible deep eutectic solvent (DES) to provide an inexpensive and attractive route that afforded the products in moderate to excellent yields. The employed DES serves both a catalytic role and as the green reaction medium. The magnetic nanocatalyst and DES can been reused several times without a significant loss of activity.

PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS

Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.

PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS

The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.